Genital human papillomavirus (HPV) infection: Viral screening and typing, interest of in situ hybridization;Infection genitale a papilloma virus humain (PVH): Depistage et typage viral, interet de l'hybridation in situ

Annales de Pathologie

Volumn 16, Issue 5, 1996, Pages 364-373

  Walker, F ^a   Darai, E ^a   Dauge Geffroy, M Ch ^a   Joannes, M ^b   Soustre, E ^a   Lehy, Th ^c   Potet, F ^a  

^a BICHAT HOSPITAL   (France)

^b Laboratoire Argene   (France)

^c INSERM   (France)

Author keywords

ISH; CIN; HPV; ISH; PCR

Indexed keywords

FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; REVIEW; UTERINE CERVIX; VIRUS INFECTION; WART VIRUS; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; UTERINE CERVIX DISEASE; VAGINA DISEASE; VIROLOGY; VIRUS GENOME; VULVA DISEASE;

FEMALE; GENOME, VIRAL; HUMANS; IN SITU HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES; VAGINAL DISEASES; VULVAR DISEASES;

EID: 0030281547     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. ZUR HAUSEN H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991 ; 184 : 9-13.
2. LOVEJOY N, ANASTASI J. Squamous cell cervical lesions in women with and without AIDS: Biochemical risk factors, prevention, and policy. Cancer Nursing 1994 ; 17 : 294-307.
3. CRUM CP, NUOVO GJ. Genital papillomaviruses and related neoplasms. Raven Press ed., 1991 ; 1-230.
4. BOND S, CARRINO ., HAMPL H, HANLEY L, RINEHARDT L, and LAFFLER T. Papillomavirus in Human Pathology. by Monsonego J., Raven Press 1990 ; 78 : 425-435.
5. DE VILLIERS. EM. The epidemiology of papillomavirus and cervical cancer. In : Munoz N., Bosch F.X., Shah K.V. et Meheus A., The epidemiology of human papillomavirus and cervical cancer. Lyon, France : The international Agency for (Research on Cancer, 1992 : eds) IARC Lyon 1992 : 111-9.
6. LE MOAL MA. et THIERRY F. Papillomavirus in Human Pathology. Monsonego (eds) ASSP Challenges of Modern Medicine 1995 ; 9 : 1-11.
7. PARK TW, FUJIWARA H, WRIGHT T. Molecular biology of cervical cancer and its precursors. Cancer 1995 ; 76 : 1902-13.
8. WERNESS BA, LEVINE PM. et HOWLEY PM. Association of human papillomavirus type 16 and 18 E6 proteins with P53. Science 1990 ; 248 : 76-79.
9. DYSON N, HOWLEY PM, MUNGER K et HARLOW E. The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989 ; 243 : 934-7.
10. SCHEFFNER M, WERNESS BA, HUIBREGTSE JM, LEVINE AJ et HOWLEY PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of P53. Cell 1990 ; 63 : 1129-36.
11. FARTHING AJ et VOUSDEN KH. Functions of human papillomavirus E6 and E7 oncoproteins. Trends in Microbiol 1994 ; 2 : 170-4
12. AMORTEGUI AJ, MEYER MP, ELBORNE VL, AMIN RM. P53, retinoblastoma gene product and cyclin protein expression in human papillomavirus virus DNA positive cervical intra epithelial neoplasia and invasive cancer. Modern Pathol. 1995; 8 : 907-12.
13. MIWA K, MIYAMOTO S, KATO H, IMAMURA T, NISHIDA M, YOSHIKAWA Y. et al. The role of P53 inactivation in human cervical cell carcinoma development. Br J Cancer 1995; 71 : 219-226.
14. MIDELANGOSH K, ALBRECHT K, JORAM S, SCHLECHT H, GIESSING M, LONING T. Presence and persistence of HPV infection and P53 mutation in cancer of the cervix uteri and the vulva. Internat J Cancer 1995 ; 63 : 639-45.
15. WALTS AE, KOEFFLER HP, SAID JW. Localization of P53 protein and human papillomavirus in anogenital squamous lesions : immunohistochemical and in situ hybridization studies in benign, dysplastic. and malignant epithelia. Hum Pathol 1993 , 24 : 1238-42.
16. JENSON AB, ROSENTHAL JD, OLSON C, PASS F, LANCASTER WD et SHAH K. Immunologic relatedness of papillomaviruses from different species. J Natl Cancer Res 1980 ; 64 . 495-500.
17. McCANCE D. Human Papillomaviruses. In : Cohen M., Hook E., Hitchcock P eds. Sexually transmitted diseases in the AIDS era: part II. Philadelphia WB Saunders. 1994 : 751-68.
18. LORINCZ AT, REID R., JENSON AB. et al. Human papillomavirus infection of the cervix: relative risk association of 15 common anogenital types. Obstet Gynecol 1992 ; 79 : 323-37.
19. MARSAN C., GESTIN E. Vrais et faux koilocytes. Revue française des laboratoires 1988; 182: 71-5.
20. The Bethesda system for reporting cervical/vaginal cytologic diagnoses: revised after the Second National Cancer Institute Workshop. Acta Cytol 1993 ; 37 : 115-24.
21. MEISELS A, FORTIN R, ROY M : Condylomatous lesions of the cervix : 2. Cytologic, colposcopic and histopathologic study. Acta Cytol 1979 ; 21 : 379.
22. RICHART RM : Causes and management of cervical intraepithelial neoplasia. Cancer 1987; 60 : 1951-1959.
23. Consensus morphologique sur les néoplasies du col utérin Paris-Tolbiac 1991. Arch Anat Cytol Path 1991 ; 39 : 185-222.
24. BRINTON L. Epidemiology of cervical cancer overview. In : Munoz N., Bosch F., Shah K., et als eds. The epidemiology of human papillomavirus and cervical cancer. Lyon, France : The international Agency for Research on Cancer, 1992 : 3-23.
25. DEAU MC, FAVRE M, ORTH G. Genetic heterogeneity among human papillomaviruses (HPV) associated with Epidermodysplasia Verruciformis : Evidence for multiple allelic forms of HPV5 and HPV18 E6 genes. Virology 1991 ; 184 : 492-503.
26. MONSONEGO J. Infection génito-anales à Papillomavirus. Impact Médecin 1994 ; 228 : 3-22.
27. MORRIS JDH, EDDLESTON ALWF, CROOK T. Viral infection and cancer. Lancet 1995 ; 346 : 754-8.
28. TING Y, MANOS M.M. Detection and typing of genital human papillomaviruses. PCR protocols : A guide to methods and applications. Academic Press 1990 ; 356-66.
29. SAIKI R.K., GELFAND D.M., STOFFEL S., SCHARFF S.J., HIGUCHI R.G., HORN G.T. et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988 ; 239 : 487-91.
30. KIEVITS T, VAN GEMEN B, VAN STRIJP D, SCHUKKINK R, DIRCKS M, Adriaanse H et al. NASBA isothermal enzymatic in vitro acid amplification optimized for the diagnosis of HIV1 infection. J Virol Meth 1991 ; 35 : 273-86.
31. SMITS HL, VAN GEMEN B, SCHUKKINK R, VAN DER VELDEN J, TJONG-A-HUNG SP, JEBBING MF et al. Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts. J Virol 1995 ; 54 : 75-81.
32. MANOS MM, TING Y, WRIGHT DK, LEWIS AJ, BROKER TR et WOLINSKI SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer cells 1989 ; 7: 209-14
33. GREGOIRE L, ARELLA M, CAMPIONE-PICCARDO J et LANCASTER WD. Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol 1989 ; 27 : 2660-65.
34. DALLAS PB, FLANAGAN JL, NIGHTINGALE BN et MORRIS BJ. Polymerase chain reaction for fast non radioactive detection of high and low risk papillomavirus types in routine cervical specimens and in biopsies. J Med Virol 1989 ; 27 : 105-11.
35. SOLLER C, ALLIBERT P, CHARDONNET Y, CROS P, MANDRAND B, et THIVOLET J. Detection of human papillomavirus type 6, 11, 16 and 18 in mucosal and cutaneous lesions by the multiplex polymerase chain reaction. J Virol Meth 1991 ; 35 : 143-57.
36. JULLIAN EH, DHELLEMMES C, SAGLIO O, CHAVINIE J, et POMPIDOU A. Improved detection of human papillomavirus types 16 and 18 in cervical scrapes by a multiplex polymerase chain reaction : a 4% prevalence amons 120 french women with normal cytology. Lab Invest 1993; 68 : 242-247.
37. URDEA MS, HORN T, FULTZ, TJ, ANDERSON M, RUNNING JA, HAMREN S et al. Branched amplification multimers for the sensitive direct detection of human hepatitis viruses. Nucleic Acids Research Symposium Series 1991 ; 24 : 197-200.
38. CLAVEL C, BINNINGER I, BOUTTERIN MC, POLETTE M, BIREMBAUT P. Comparison of four non-radioactive and 35S-based methods for the detection of human papillomavirus DNA by in situ hybridization. J Virol Meth 1991; 33 : 253-266.
39. WALKER F, BEDEL C, BOUCHER O, DAUGE MC, VISSUZAINE C, POTET F. L'amplification génique in situ sur coupes tissulaires (PCR in situ) : Une nouvelle technique pour le pathologiste. Ann Pathol 1995 . 15 : 459-65.
40. NUOVO GJ PCR in situ hybridization : protocols and applications. Second Edition. Raven Press 1994 ; 1-437.
41. KOMMINOTH P, LONG AA. In situ polymerase chain reaction : An overview of method, applications and limitations of a new molecular technique. Virchows Archiv B Pathol 1993 ; 64 : 67-73.
42. WALKER F, BEDEL C, DAUGE-GEFFROY MC, LEHY T, MADELENAT P, POTET F Improved detection of HPV infection in genital intraepithehal neoplasia in HIV + women by polymerase chain reaction-in situ hybridization (PCR-ISH). Diagn Mol Path, 1996 ; 5 : 136-46.
43. BERNARD C, MOUGIN C, BETTINGER D, DIDIER JM, LAB M. Detection of human papillomavirus by in situ polymerase chain reaction in paraffin embedded cervical biopsies. Mol cellular probes 1994 ; 8 : 337-43.
44. MITCHELL H, DRAKE M, MEDLEY G Prospective evaluation of risk of cervical cancer after cytological evidence of human papillomavirus infection. Lancet 1986 ; 1(8481) : 573-5.
45. CAMPION MJ, McCANCE DJ, CUZICK J et al. Progressive potential of mild cervical atypia : prospective cytological, colposcopic, and virological study. Lancet 1986 ; 2 (8501) : 237-240.
46. KOUTSKY LA, HOLMES KK, CRITCHLOW CW, STEVENS CE, PAAVONEN J, BECKMAN AM et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992 ; 327 : 1272-78.
47. BAUER HM, TING Y, GREER CE et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991 ; 165 : 472-477.
48. HILDESHEIM A, SCHIFFMAN MH, GRAVITT E et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994 ; 169 : 235-40.
49. Mc DOUGAL JK Cofactors in the progression of HPV-associated tumors. Antibiot Chemother 1994 ; 46 : 150-64.
50. MONSONEGO J. Rôle des cofacteurs dans la carcinogénèse viroinduite des épithéliums malpighiens des voies génitales basses. Gynécologie 1988 ; 39 : 435-44.
51. QUEREUX C, HOURDEQUIN Ph, SANIEZ D, RÉMY G. Pathologie du col et immunodépression. Contracept Fertil Sex 1994 ; 22 : 771-6.
52. WRIGHT TC, KOULOS J, SCHNOLL F, SWANBECK J, ELLERBROCK TV, CHIASSON MA et al. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus/ Outcome after loop electrosurgical excision. Gynecol Oncol 1994 ; 55 : 253-8.
53. MANDELBLATT JS, FAHS M, GARIBALDI K, SENIE R, PETERSON H. Association between HIV infection and cervical neoplasia : implications for clinical care of women at risk for both conditions. AIDS 1992; 6 : 173-8.
54. LAGA M, ICENOGLE JP, MARSELLA R, MANOKA AT, NZILA N, RYDER RW et al. Genital papillomavirus infection and cervical dysplasia opportunistic complications of HIV infection. Int J Cancer 1992 ; 50 : 45-8.
55. MAIMAN M, FRUCHTER RG, SERUR E, LEVINE P, ARRASTIA CD, SEDLIS A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus seropositive women. Obstet Gynecol 1993 ; 52 : 170-4.
56. JOHNSON JC, BURNETT AF, WILLET GD, YOUNG MA, DONIGER J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992 ; 79 : 321-7.
57. MAIMAN M. Cervical neoplasia in women with HIV infection. Oncology 1994 ; 8 : 83-94.
58. BRAUN L. Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia. Am J Pathol 1994 ; 144 : 209-14.
59. NUOVO GJ, FORDE A, MAC CONNELL P, FAHRENWALD R. In situ detection of PCR-Amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am J Pathol 1993 ; 143 : 40-8.
60. MORELLI AE, SANANES C, DI PAOLA G, PAREDES A, FAINBOIM L Relationship between types of human papillomavirus and langerhans' cells in cervical condyloma and intraepithelial neoplasia. Am J Clin Pathol 1993 ; 99 : 200-6.
61. SPINILLO A, TENTI P, ZAPPATORE R, DE SETA F, SILINI E, GUASCHINO S. Langerhans' cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection. Gynecol Oncol 1993 ; 48 : 210-3.
62. VERNON SD, HART CE, REEVES WC, ICENOGLE JP. The HIV1 tat protein enhances E2 dependent human papillomavirus 16 transcription. Virus Research 1996 ; 27 : 133-45.
63. MAIMAN M, FRUCHTER RG, GUY L, CUTHYLL S, LEVINE P, SERUR E. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993 ; 71 : 402-6.
64. Centers for Disease Control and Prevention. 1993 sexually transmitted diseases treatment guidelines. MMWR 1993 ; 42 : 1-102.
65. LORINCZ A. Detection of human papillomavirus DNA without amplification : prospects for clinical utility. In : Munoz N, Bosch F, Shah K. et als eds. The epidemiology of human papillomavirus and cervical cancer. Lyon, France : The international Agency for Research on Cancer 1992 : 135-45.
66. JACQUEMIER J, CLAVEL C, BIREMBAUT P. Faut-il typer les papillomavirus dans les lésions génito-anales ? Ann Pathol 1991 ; 11 : 77-9.
67. LAVAL C, LE DOUSSAL V, PRATILI MA : Les papillomavirus (HPV) en pathologie cervicale utérine : Implications cliniques, indications du typage. Bull Cancer, 1990 ; 77 : 321-30.
68. MONSONEGO J, ALONSO JM, SAUREL J. Infections génito-anales à papillomavirus. Diagnostic. Impact médecin 1994 ; 227 : 9-15.
69. AUTILLO-TOUATI A, BENMOURA D, PALAZZI D, ROBAGLIA A, TASSO F, BLANC B, et al. Quatre années de dépistage sur frottis cervical des lésions du col utérin. J Gynecol Obstet Biol 1992 ; 21 : 754-60.
70. YOUNG J, CHOI MD. Detection of human papillomavirus DNA on routine Papanicolaou's smears by in situ hybridization with the use of biotinylated probes. Am J Clin Pathol 1990 ; 95 : 475-80.
71. ZARCONE R, ADDONIZIO D, VOTO RI, GARDONE G, DI STEFANO M, CARDONE A. HPV and HIV : HPV-DNA identification of colpocytologic smears in HIV positive females through « in situ » hybridization technique. Clin Exp Obst Gyn 1994 ; 21 : 160-3.
72. REID R, GREENBERG MD, LORINCZ AT, JENSON AB, LAVERTY AB, HUSAIN CR. Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection ? Am J Obstet Gynecol 1991 ; 164 : 1461-71.
73. COLE H. Diagnostic and therapeutic technology assessment (DATTA) : human papillomavirus DNA testing in the management of cervical neoplasia. JAMA 1993 ; 270 : 2975-81.
74. CORN BW, LANCIANO RM Combined modality treatment for carcinomas of the uterine cervix and vulva. Curr Opinion Oncol 1994 ; 6 : 524-30.
75. JOURDAN ML, STEPHANOV E, BODY G, GOUDEAU A, FETISSOF F. Lésions intraépithéliales du col utérin et papillomavirus humains : Etude comparative des données de l'histologie et de l'hybridation in situ. Arch Anat Cytol Path 1993 ; 3-4 : 149-58.
76. BERGERON C, BARASSO R, BEAUDENON S, FLAMANT P, CROISSANT O, ORTH G. Human papillomaviruses associated with cervical